First-in-Human Clinical Safety Trial is Successfully Launched using ReSolv™, the Unique Polymer-Based Flow-Diverting Stent Designed to Treat Brain Aneurysms Company Advisory Board Expands to Include Respected Medical Key Opinion Leader and Medtech Entrepreneur CALGARY, AB, June 1, 2023 /PRNewswire/ – Fluid Biomed Inc., a medical device company developing ReSolv™, the world’s first hybrid […]